[{"NetIncomeLoss_2_Q2_USD":-43032000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":21489000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-1997000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-26210000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-44706000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":1116000.0,"PaymentsToAcquireInvestments_2_Q2_USD":1040475000.0,"Depreciation_2_Q2_USD":9266000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-801245000.0,"AssetsCurrent_0_Q2_USD":2302346000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q2_USD":2924000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-236109000.0,"DerivativeLiabilitiesCurrent_0_Q2_USD":7064000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":34096000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":266918000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q2_USD":4500000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":170572000.0,"AccruedRoyaltiesCurrent_0_Q2_USD":6031000.0,"RepaymentsOfSecuredDebt_2_Q2_USD":16693000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2_Q2_USD":6670000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":575000000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":0.0,"LongTermDebt_0_Q2_USD":2103056000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":45403000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_2_Q2_USD":-449000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_1_Q2_USD":85000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":243395000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q2_USD":275499000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":133179000.0,"ShareBasedCompensation_2_Q2_USD":59258000.0,"Assets_0_Q2_USD":6066501000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":1696082000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":451000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":42582000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":21219000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":4440000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_1_Q2_USD":27680000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_2_Q2_USD":52588000.0,"ContractWithCustomerLiability_0_Q2_USD":7221000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":191406000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":399806000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-3496000.0,"LongTermDebtCurrent_0_Q2_USD":33387000.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1_Q2_USD":176260000.0,"OperatingLeaseLiability_0_Q2_USD":157027000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":25912000.0,"Investments_0_Q2_USD":910000000.0,"DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_0_Q2_USD":1454000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":500000000.0,"CommonStockValue_0_Q2_USD":6000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":54754000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":3467000.0,"AccountsReceivableNetCurrent_0_Q2_USD":351920000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-4475000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-6972000.0,"PrepaidExpenseCurrent_0_Q2_USD":49109000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":500000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":55864000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-356000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":215415000.0,"RepaymentsOfConvertibleDebt_2_Q2_USD":332888000.0,"EarningsPerShareBasic_1_Q2_USD":2.07,"EarningsPerShareBasic_2_Q2_USD":-0.77,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":1004319000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":202430000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-1982000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":10078000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":55684000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":3290445000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-1596000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-464000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":24251000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":2499135000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":565000000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":144264000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":786082000.0,"OtherAssetsNoncurrent_0_Q2_USD":48828000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":125821000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":62974000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":5264000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":51289000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":136128000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-55748000.0,"IncreaseDecreaseInInventories_2_Q2_USD":18826000.0,"OtherAssetsCurrent_0_Q2_USD":112701000.0,"CostsAndExpenses_1_Q2_USD":364310000.0,"CostsAndExpenses_2_Q2_USD":1088710000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":494851000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":78922000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":165029000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.319,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":-0.092,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":23786000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-2360000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":44853000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":562436000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_2_Q2_USD":205250000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":15856000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":455488000.0,"DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_0_Q2_USD":7244000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":20730000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-9260000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":30599000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":14663000.0,"Goodwill_0_Q2_USD":918021000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_1_Q2_USD":3000000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":0.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":21327000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-12716000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":58269000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":170572000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":-1897000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":-1715000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":2360000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":170572000.0,"EarningsPerShareDiluted_1_Q2_USD":2.06,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":16693000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.77,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":55684000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":21203000.0,"NetIncomeLoss_1_Q2_USD":114801000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":128259000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":162376000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":33387000.0,"OperatingLeasePayments_2_Q2_USD":11404000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":2286126000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":6547000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":113000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":55413000.0,"ShortTermLeaseCost_1_Q2_USD":890000.0,"SubleaseIncome_1_Q2_USD":67000.0,"SubleaseIncome_2_Q2_USD":224000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.053,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":2286126000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":24854000.0,"LongTermDebtNoncurrent_0_Q2_USD":2069669000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":786082000.0,"AccountsPayableCurrent_0_Q2_USD":50043000.0,"LiabilitiesCurrent_0_Q2_USD":409960000.0,"ShortTermLeaseCost_2_Q2_USD":1760000.0,"ProceedsFromConvertibleDebt_2_Q2_USD":981381000.0,"UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths_0_Q2_USD":71700000.0,"AssetImpairmentCharges_1_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":6066501000.0,"OperatingLeaseCost_1_Q2_USD":5410000.0,"OperatingLeaseCost_2_Q2_USD":10700000.0,"ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_2_Q2_USD":-1068000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-82768000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":3290445000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":3633000.0,"InvestmentIncomeInterest_1_Q2_USD":3100000.0,"InvestmentIncomeInterest_2_Q2_USD":7600000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":517494000.0,"StockRepurchasedAndRetiredDuringPeriodValue_1_Q2_USD":7484000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":45481000.0,"OciBeforeReclassificationsNetOfTaxAttributableToParent_2_Q2_USD":-13784000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q2_USD":597000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2_Q2_USD":-3456000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":146537000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":171452000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-37850000.0,"OperatingIncomeLoss_1_Q2_USD":198126000.0,"OperatingIncomeLoss_2_Q2_USD":8452000.0,"InventoryNet_0_Q2_USD":92534000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":59258000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":30604000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":186528000.0,"AssetImpairmentCharges_2_Q2_USD":136139000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-3640000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":148738000.0,"LeaseCost_1_Q2_USD":6233000.0,"LeaseCost_2_Q2_USD":12237000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":878246000.0,"VariableLeaseCost_1_Q2_USD":0.0,"VariableLeaseCost_2_Q2_USD":1000.0,"TaxesPayableCurrent_0_Q2_USD":55979000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":24793000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":1696082000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":2418073000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":7520000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":3588000.0,"AccruedMarketingCostsCurrent_0_Q2_USD":3420000.0,"StockholdersEquity_0_Q2_USD":3141805000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":134839000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":533000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":130647000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":12763000.0,"DeferredFinanceCostsNoncurrentNet_0_Q2_USD":6347000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":1097162000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":6221000.0,"Ticker":"JAZZ","CIK":"1232524","name":"JAZZ PHARMACEUTICALS PLC","OfficialName":"Jazz Pharmaceuticals plc Common Stock (Ireland)","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"10281986580.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200804"}]